[1] 邢蒙,刘晋津.踝肱指数联合血管内皮功能对2型糖尿病合并冠心病患者冠状动脉狭窄程度的预测价值[J].医学临床研究,2021,38(9):1055-1058. [2] 李渊,徐桂冬,王熙,等. 急性心肌梗死合并2型糖尿病患者直接经皮冠脉介入治疗术后的随访研究[J].南京医科大学学报(自然科学版),2018,38(4):97-100. [3] AL-LAMEE R K,NOWBAR A N,FRANCIS D P. Percutaneous coronary intervention for stable coronary artery disease [J].Heart,2019,105(1):11-19. [4] RAO G,SHETH S,GRINES C. Percutaneous coronary intervention:2017 in review [J].J Interv Cardiol,2018,31(2):117-128. [5] 王东方,滕伟,王鲜花. 急性心肌梗死患者HbA1c水平与PCI术后支架内再狭窄的相关性[J].中国实用医刊,2020,47(13):33-36. [6] WANG F,LI C,DING FH,et al. Increased serum TREM-1 level is associated with in-stent restenosis,and activation of TREM-1 promotes inflammation,proliferation and migration in vascular smooth muscle cells [J].Atherosclerosis,2017,267:10-18. [7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344. [8] 张劭彦. 64排螺旋CT冠脉造影与DSA冠脉造影评定冠心病PCI术后支架内再狭窄的对照研究[J].中国医学创新,2019,16(15):106-109. [9] HOSEINI A,NAMAZI G,FARROKHIAN A,et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease [J].Food Funct,2019,10(9):6042-6051. [10] GIANNINI F,CANDILIO L,MITOMO S,et al. A practical approach to the management of complications during percutaneous coronary intervention [J].JACC Cardiovasc Interv,2018,11(18):1797-1810. [11] 张丽,李侠,潘长江,等. 老年人冠状动脉支架术后支架内再狭窄和再闭塞危险因素分析[J].中华老年医学杂志,2018,37(3):260-263. [12] HELLER S R,BERGENSTAL R M,WHITE W B,et al. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events:the examine trial [J].Diabetes Obes Metab,2017,19(5):664-671. [13] EDEL Y,KLIMINSKI V,POKROY-SHAPIRA E,et al. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome [J].Arthritis Res Ther,2019,21(1):10-13. [14] 王振,徐通达,李东野. 冠心病合并糖尿病经皮冠状动脉介入治疗术后支架内再狭窄预测因素分析[J].安徽医药,2019,23(9):1821-1825. [15] 方喜波,洪书新,刘培敏. sTREM-1对急性心肌梗死患者支架内再狭窄的预测价值[J].心脑血管病防治,2020,20(3):51-54.
2023, Vol. 40 
